DM
David Manjarres
OtherActiveGeneral Partner at Seventure Partners
76
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for David Manjarres.
Investment Thesis & Strategy
Seventure Partners invests in various stages across biotech, climatetech/cleantech, healthcare, fintech, and robotics/hardware, seeking innovative companies with high growth potential.
Portfolio Companies
Selected investments from their portfolio of 76 companies
S
Studitemps
Other · , 0
P
Presto Engineering
Other · Growth, 0
L
LiMM Therapeutics
Biotech · Seed, 0
S
String Bio
Other · , 0
L
LNC Therapeutics
Other · , 0
M
MOVE ‘N SEE
Other · , 0
w
wealthpilot
Other · , 0
O
Opencell Software
Other · , 0
H
HorseCom
Other · , 0
I
Il Etait Un Fruit
Other · , 0
F
FIRE1
Other · , 0
V
Virovet
Biotech · Seed, 0
Frequently Asked Questions
David Manjarres focuses on Series B stage investments.